Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.440
-0.230 (-8.61%)
Mar 6, 2026, 4:00 PM EST - Market closed
LIXT Market Cap
LIXT has a market cap or net worth of $21.26 million as of March 6, 2026. Its market cap has increased by 585.74% in one year.
Market Cap
21.26M
Enterprise Value
18.37M
1-Year Change
585.74%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $21.26M, a decrease of -55.15%. That is a compound annual growth rate of -14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.90M | -37.95% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 23.01M |
| Daré Bioscience | 21.86M |
| IO Biotech | 21.62M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |